Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olomoucine (CAS 101622-51-9)

5.0(1)
Write a reviewAsk a question

See product citations (12)

Alternate Names:
2-(2-Hydroxyethylamino)-6-benzylamino-9-methylpurine
Application:
Olomoucine is a potent and selective inhibitor of Cdc2 and ERK1
CAS Number:
101622-51-9
Purity:
≥98%
Molecular Weight:
298.34
Molecular Formula:
C15H18N6O
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Olomoucine is a purine that acts as a competitive inhibitor of a variety of cell cycle regulating proteins with high specificity, which leads to the blockage of some cell cycle steps. The compound inhibits: Cdc2/cyclin B, Cdk2/cyclin A and Cdk2/cyclin E kinases, the brain Cdk5/p35 kinase and the ERK1/MAP-kinase. Olomoucine does not significantly inhibit Cdk4/cyclin D1 and Cdk6/cyclin D3 kinases. The compound can induce cell arrest at G1/S and the G2/M, due to its effect on Ckd2 and Cdcd2. Olomoucine also behaves as a competitive inhibitor for ATP and as a non-competitive inhibitor for histone H1 in terms of being Cdk substrates.


Olomoucine (CAS 101622-51-9) References

  1. Differential effects of 6-DMAP, olomoucine and roscovitine on Xenopus oocytes and eggs.  |  Flament, S., et al. 2000. Zygote. 8: 3-14. PMID: 10840869
  2. The Cdk5 inhibitor olomoucine promotes corneal debridement wound closure in vivo.  |  Tripathi, BK., et al. 2008. Mol Vis. 14: 542-9. PMID: 18385789
  3. Olomoucine inhibits cathepsin L nuclear translocation, activates autophagy and attenuates toxicity of 6-hydroxydopamine.  |  Fei, XF., et al. 2009. Brain Res. 1264: 85-97. PMID: 19368812
  4. The radiosensitising effect of olomoucine derived synthetic cyclin-dependent kinase inhibitors.  |  Korinkova, G., et al. 2010. Neoplasma. 57: 161-9. PMID: 20099981
  5. Synergistic actions of olomoucine and bone morphogenetic protein-4 in axonal repair after acute spinal cord contusion.  |  Chen, L., et al. 2014. Neural Regen Res. 9: 1830-8. PMID: 25422646
  6. Down-regulation of BNIP3 by olomoucine, a CDK inhibitor, reduces LPS- and NO-induced cell death in BV2 microglial cells.  |  Tsou, YC., et al. 2016. Neurosci Lett. 628: 186-93. PMID: 27345388
  7. Differential effects of the cell cycle inhibitor, olomoucine, on functional recovery and on responses of peri-infarct microglia and astrocytes following photothrombotic stroke in rats.  |  Yew, WP., et al. 2021. J Neuroinflammation. 18: 168. PMID: 34332596
  8. Olomoucine, an inhibitor of the cdc2/cdk2 kinases activity, blocks plant cells at the G1 to S and G2 to M cell cycle transitions.  |  Glab, N., et al. 1994. FEBS Lett. 353: 207-11. PMID: 7523194
  9. Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases.  |  Abraham, RT., et al. 1995. Biol Cell. 83: 105-20. PMID: 7549905
  10. Inhibition of cyclin-dependent kinases by purine analogues.  |  Veselý, J., et al. 1994. Eur J Biochem. 224: 771-86. PMID: 7925396

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Olomoucine, 5 mg

sc-3509
5 mg
$72.00

Olomoucine, 25 mg

sc-3509A
25 mg
$274.00

How is a stock solution made for this product?

Asked by: hawkeye11
Thank you for your question. A stock solution of Olomoucine, sc-3509A, may be made by dissolving the olomoucine in an organic solvent purged with an inert gas. Olomoucine is soluble in organic solvents such as ethanol, DMSO, and dimethylformamide (DMF). The solubility of olomoucine in these solvents is approximately 10, 20, and 30 mg/ml, respectively.
Answered by: TechService7
Date published: 2017-01-25
  • y_2026, m_4, d_23, h_7CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.43
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_1
  • loc_en_US, sid_3509, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getContent, 107ms
  • QUESTIONS, PRODUCT
Rated 5 out of 5 by from EideEide, et. al. (PubMed ID 12740381) used olomoucine, a specific Cdc inhibitor, to inhibit replication in order to confirm that 32P labeling in G1 nuclei was due to the initiation of replication. -SCBT Publication Review
Date published: 2015-01-12
  • y_2026, m_4, d_23, h_7
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.43
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_3509, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getReviews, 17ms
  • REVIEWS, PRODUCT
Olomoucine is rated 5.0 out of 5 by 1.
  • y_2026, m_4, d_23, h_7
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.43
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_3509, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getAggregateRating, 106ms
  • REVIEWS, PRODUCT